Animal studies were conducted to evaluate the cell response and chemical potentiality of a synthetic bioactive resorbable graft (SBRG) made of nonceramic cluster particulate of low-temperature HA material. The study evaluated bone-bridging of the SBRG particulates in 1 mm wide implant channels of 5 × 8 mm long roughened titanium interface in 6 dogs and compared results to the same implant channels left empty as controls at 6-and 12-week intervals. Resorption rate capacity and cell response were evaluated with an assessment of the chemical characterization of the synthetic nonceramic material next to the titanium implant interfaces. Results of the animal studies were compared with human histologic biopsies of the SBRG for bone quality, density, and bone growth into defect sites concurrent with resorption time of the graft. One human biopsy consisted of a graft mixture of the SBRG and dense bovine-derived HA, compared under the electron microscope, including histology by H and E staining. Part 1 of this paper presents evidence of the predictability and efficacy of the SBRG osteoconductive, particulate chemical potentiality to aid in the regeneration of lost bone anatomy next to titanium implant interfaces. Recent technological innovations in computer hardware and software have given clinicians the tools to determine 3-dimensional quality and density of bone, including anatomical discrepancies, which can aid in the diagnosis and treatment planning for grafting procedures. When teeth are extracted, the surrounding bone and soft tissue are challenged as a result of the natural resorptive process. The diminished structural foundation for prosthetic reconstruction, with or without implants, can be compromised. A synthetic bioactive resorbable graft material having osteoconductive biochemical and biomechanical qualities similar to the host bone provides the means to improve compromised bone topography for ridge preservation, ridge augmentation, or to enhance the bony site for implant placement and subsequent prosthetic rehabilitation. Part two of this paper will demonstrate clinical applications of the SBRG material for purposes of implant placement and prosthetic reconstruction.
INTRODUCTION
Bone grafting has become a valuable mainstream clinical procedure, regardless of whether it is manufactured from organic or synthetic sources, which can be utilized in a variety of applications. Ridge preservation after tooth extraction can be important to preserve edentulous areas for later denture support, fixed bridge applications, implant reconstruction, and therapeutic maintenance of facial morphology by osseous reconstruction. Onlay grafts and combination bone grafts for sinus augmentation and periodontal procedures by the use of a synthetic bioactive resorbable grafts (SBRG) have become more predictable as treatment alternatives to restore form and function. [1] [2] [3] A variety of organically derived and synthetic dense bone formulations have been experimentally used as mixtures for the therapeutic repair and restoration of osseous ridge defect sites, posttooth extraction (including periodontal reconstruction), sinus augmentation with implants, and cyst removals with questionable results. [4] [5] [6] Various resorbable and nonresorbable materials have been developed to provide clinicians with bone substitutes that can be used to enhance new bone formation next to the titanium implant interface. Resorbable materials have been the product of choice for new bone growth followed by implant placement because of the materials that have chemical and mechanical properties similar to bone. [7] [8] [9] Although, autogenous bone grafts may be considered the optimal choice for augmentation, the procedure usually requires harvesting bone from a distant donor site and can be self-limiting with associated risks of complications to the patient and required restoration of the remaining defect site. [10] [11] [12] [13] [14] Demineralized freeze-dried bone allograft (DFDBA) or frozen bone from human cadavers as an alternative source raises concerns because of the possible inconsistency of results and the possibility of donor sources transmitting infectious diseases. 15 Results of clinical and histologic studies suggest that DFDBA used today may have little or no osteoinductive/conductive capacity. 16 In a related study, Becker et al 17 concluded that not only does DFDBA not induce bone formation, but most importantly, it will not resorb, maintaining a spongy consistency that will interfere with ossification processes and act as an inhibitor to mineralization. Patient aversion to human necrotic tissue graft and the risk of being subjected to possible viral infection from HIV donors is justified. As documented, the cases of disease transmission from osseous tissue by a seronegative donor have occurred. 18 The Federal Register published letters from the US Food and Drug Administration that addressed the transmission of highly infectious diseases with warning that "available scientific information indicated that these agents (bovine spongiform encephalopathy [BSE]) are extremely resistant to inactivation by normal disinfection or sterilization procedures." [19] [20] [21] Although, naturally derived materials, either human or bovine, are treated with gamma radiation, the possibility of disease transmission remains and must be seriously considered. The nature of organic material and the processing procedures of high heat or radiation may cause these materials to crystallize and harbor endotoxins or dormant pathogens. 18, 22 Ceramics, bovine, glass, and ceramic HA particulate materials merely act as filler materials because of their sintering density at high temperatures. These materials are subcategorized as nonresorbable, which can produce clinical complications, such as fibrous tissue encapsulation, especially when used next to metallic dental implants. [23] [24] [25] Animal and human studies have concluded that "nonresorbable" materials act as barriers to bone-forming cells and behave as irritants because of their chemical and mechanical densities, which result in exfoliation, fragmentation, and the migration of such particulates to other organs. Fragmentation of these materials and the transport by giant cells of such dense particulates can settle in regional lymph nodes, lungs, and the spleen resulting in the functional interference of these organs with systemic complications. 26, 27 To avoid biologic, systemic, and disease transmission complications, a nonautogenous bone graft material should ideally be nonantigenic, bioactive, osteoconductive, and synthetically derived with a clinically acceptable time frame of resorption by the majority of such material (i.e. 6 months). Such material should have chemical and mechanical properties relatively similar to the host trabecular bone and possess a bioactive resorptive chemical potentiality to induce favorable cellular response for new bone formation by the action of ionization into calcium and phosphate ions in a chemotactic state. A nonceramic bioactive bone augmentation material that meets these specifications has been commercially available for the past 15 years. It is provided as a sterile, biocompatible, and highly osteoconductive resorbable material with safer and more effective clinical results. This bioactive material of low-temperature HA cluster particulate (OsteoGen, Impladent Ltd, Holliswood, NY) mimics the structural configuration of bone trabeculation in a cluster-type format.
In numerous clinical and animal studies, when compared to various alloplastic materials, the resorbable lowtemperature SBRG has been shown to produce better clinical results than surgical debridement alone or defects filled with dense particulate materials. [28] [29] [30] [31] In a review of the literature, the greatest success and biocompatibility of alloplastics was obtained with a lowtemperature, synthetic, bioactive, calcium phosphate, resorbable material having a highly osteoconductive chemical potential. As the majority of resorption occurs between 4, 6, and 8 months postoperatively (depending on material quantity delivered, patient metabolic state, and vascularity), 80% of the material resorbs and the restored site is radiopaque demonstrating a state of high mineralization and bone densification. [32] [33] [34] [35] A 3.5-year clinical study using SBRG in conjunction with titanium implants for sinus elevation followed with histologic observation showed dense mineralization. 36 However, close examination of the histologic slide revealed the use of ceramic materials followed by their migration and fibrous tissue encapsulation ( Figs 1A and B) . The ceramic material was placed as an overlay graft to add bulk to the ridge and to "enhance pontic adaptation and help prevent tissue invagination." 37 It bears noting that material migration of the ceramic material did occur from the superior area of the implant ridge downward to the defect site followed by material fragmentation and transport to regional organs.
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MATERIALS AND METHODS
The physiologic response of OsteoGen, an SBRG of lowtemperature HA, was investigated in an animal model by packing (grouting) the material in titanium implant channels measuring 5 × 8 × 1 mm apart, which were subsequently implanted in the lateral distal femur of 6 dogs. Our study evaluated the bioactive, osteoconductive resorption rate, bone bridging, and cell response of the SBRG next to the titanium implant interface. Out of three dogs each were sacrificed in 6 and 12 weeks postoperatively. Undecalcified specimens were fixed in acrylic blocks for light microscopy and microradiography and stained using Masson, von Kossa, or trichrome techniques. Six titanium chambers consisting of 40 implant channels were evaluated: 20 channels as controls and 20 as experiments with this crystal cluster particulate material. Controls were filled with intramedullary blood opposing the titanium implant interface. The experimental channels were hand-packed with a slurry of 5 ml of blood and 3 g of sterile SBRG. The study examined the materials' resorptive capacity, osteoconductivity for bone bridging next to a titanium implant, chemotactic potentiality to induce cell response for new bone formation, and the process of ionization or resorption by a bioactive device. Crystal morphology, density, and chemical composition of the material provided the key mechanism for controlled resorption in situ. Structurally, the particulate mimics the spicules of bone trabeculation by its cluster-like format providing a trellis mechanism for hydrophilic and bioactive response for cell attraction through the process of progressive resorption and chemical attraction (Fig. 2) . The crystal-size distribution of the clusters enhances bulk density for an ideal time resorption mechanism of this bone augmentation material. Individual clusters may reach a maximum size of 600 μm. Due to its low aqueous buoyancy, the material must be packed in defect sites aggressively for better osseous restoration by controlling excessive bleeding and empty spaces. 
JAYPEE
The proprietary manufacturing process is by a lowtemperature precipitation/hydrolysis mechanism in a controlled environment for crystal growth and maturation. The SBRG is not sintered like ceramic HA. By avoiding high temperatures, the material does not lose its natural state of the HA synthetic bone composition and crystal morphology for Ca 10 (Fig. 3A) . By contrast, infrared spectroscopy of ceramic HA revealed the absence of OH and CO 3 -2 , which classifies that material as an oxyapatite. 40 The splitting of the phosphorus-oxygen bending mode is a measure of higher crystallinity, size, and perfection. In SBRG and biologic apatites, the band is identified by higher splitting at 550 to 600 cm -1 , indicative of higher crystallinity and crystal maturation. A high-temperature ceramic HA shows that the crystal structure is distorted or destroyed by the heating process (Fig. 3B) . This results in a crystal structure that is not like biologic apatite or SBRG and will not resorb within an acceptable and effective clinical time-related benefit. SBRG is chemically and crystallographically similar to human bone mineral and not related to high-temperature ceramic HA. A cross-reference to X-ray diffraction analysis for HA, as per American Society for Testing and Materials powder diffraction protocol 9-432, confirmed the infrared analysis indicating that no phases other than crystalline HA were present for SBRG. X-ray characterization of the SBRG has identified 2 minor constituents to be crystalline phases of the brushite/monetite category. Animal studies by Urist and Dowell 41 and others [41] [42] [43] have identified the chemical potentiality of brushite/monetite or variations thereof, which may include octacalcium phosphate, to be a precursor and a seeding mechanism in the first stage of bone mineralization in an embryonic environment. [42] [43] [44] Histologically, the blood in all 20 commercially pure titanium implants of the control channels were completely replaced by loose fibrous connective tissue at both time periods. These channels had small amounts of newly formed bone (only 1 mm) that extended into the channels on either end. Some osteoblasts were seen in the network of thin trabecular woven bone formation. A 75 to 100 μm layer of fibrous tissue was seen separating the titanium interface from and a peak at 1450 cm -1 for the CO 3 (carbonate) group, indicating higher crystallinity than biologic HA, but with overall similarity to the biological mineral. A comparison of the infrared spectra of OsteoGen and ceramic HA shows considerable differences between them, which is indicative of the high-temperature treatment of the ceramic material that makes the ceramic very different than the SBRG. It is these differences that make SBRG resorbable and ceramic nonresorbable. (B) Infrared of ceramic HA is quite different from that of SBRG. Note the absence of OH and CO 3 bands. The broadening of peaks at 750 to 1450 cm -1 are indicative of dense materials (i.e. ceramic, bovine, etc.). This broadening indicates distortions in the crystal lattice due to high-temperature processing and chemical conversion to oxyapatite (not a true HA product) the woven bone. By the 12th week, the tissue at some areas was as much as a 200 μm layer of connective tissue seen separating the commercially pure titanium interface. Osteoid was seen on less of the trabecular surfaces than in earlier time periods. Both bone and soft tissue exhibited more mature characteristics in 12 weeks than in 6 weeks. By the 12th week, the trabeculae had progressed further in less than half of the channels. The remaining connective tissue had matured becoming less cellular and more organized (Fig. 4A) .
The presence of the SBRG low-temperature, osteoconductive, resorbable bone augmentation materials within the channels significantly enhanced the ingrowth of bone through and up against the commercially pure titanium with little or no fibrous tissue 1 or 2 layers thick between the bone and the commercially pure titanium interface (Fig. 4B) .
Microradiographic comparison of individual crystals next to the ingrowth of bone showed extensive bone attachment to the SBRG crystals and bone maturation in the process of osteonlike formation. Some haversian canals are seen as black holes, which represent marrow cavities becoming narrower in size over time. This continuous bone maturation inside the haversian canals represents the continuous bone buildup in a circumferential layering fashion through the osteoblastic synthesis by the cells (Fig. 5) .
Scanning electron micrograph analysis of a fractured crystal specimen at 6 weeks showed evidence of direct bone trabeculation attachment to the SBRG crystal particulates. This crystal sample shows cell proliferation and attachment with high binding capacity to their surfaces. Crystallographically, the fractured crystal can be identified by its small parallel crystallite structure having an uniaxial laminated arrangement. The crystals are identifiable by their tetragonal or hexagonal shape having ultrastructural architecture similar to biologic HA. This uniaxiallaminate crystallite arrangement, in the order of 500 to 1000Å, is ideal for cell mediation and resorption by hydrolysis ( Fig. 6 ; see arrow). In contrast, ceramic HA, glass, plastic, and bovine bone are monolithic, and some are dense. Their relationship to cellular activity is by fibroencapsulation, especially under load. In comparison to the size of the monolithic-dense particulates, the macrophages and giant cells are too small and the cells will fragment the dense particulates and transport these materials to the regional lymph nodes, lungs, and spleen for further processing interfering with the normal function of such organs. 26, 27 The primary characteristic of the osteoblast cell is the mineralization caused by the laying down of a procollagen matrix as the foundation for new bone formation. The 12-week specimens and radiographic examinations of the implant chambers filled with SBRG showed complete filling of all channels with new bone. The trabeculae had progressed further than the 6-week specimens and had thickened and bridged through the channels exhibiting lamellar remodeling (von Kossa stain) (Fig. 7) . In 6 weeks, the ingrowth of bone was seen to be a vascular woven bone with thin trabeculae, including osteoid tissue (red area) and numerous osteoblasts in the process of new bone formation in a lamellar fashion. In some areas of the bone, it had thickened to form circumferential structures of osteons. The ingrown bone was shown to surround the remaining SBRG crystals and formed a direct bond attachment to the particles without any visible interposing tissue (Masson stain) (Fig. 8) . A photomicrograph of the 12-week SBRG specimen next to the titanium implant interface showed mature bone formation (Fig. 9, dark blue area) . The few remaining larger crystals showed surface pitting with rounded corners denoting a time-related controlled resorption mechanism by a denser and larger crystal. The red area shows the presence of osteoblast cells. At their dormant state the cytoplasm of the osteoblast cell stain light pink. When the cells are red or darker, they are at their active state, exhibiting active bone mineralization indicated by their cytoplasmic basophilic response (dark red or light purple; Figs 8 and 9 ). In comparison to the 6-week histologic slide (Fig. 8) , note the darker blue color characteristic of well-organized and denser bone. Developing osteons are seen at different stages of remodeling and formed by the progressive and continuous buildup of concentric bony lamellae (Fig. 10) . Their haversian canals (small black circles) of marrow-filled cavities narrows in size through the osteoblastic synthesis of new bone formation. This process will be followed by osteoclastic activity and the subsequent enlargement of the haversian canals showing larger black circles. As this destruction ceases, the process of osteoblastic activity begins once more. This phenomena will be repeated 3 times within an approximate course of 142 days depending on the metabolic activity of the host. One indication of the SBRG having similar mechanical properties to the host is the fracture line of bone traversing across the crystal structure without the particulates dislodging or fibroencapsulating within the new osseous structure after loading (noted in the boxed areas of Fig. 10 ). This benefit is indicative of synthetic materials having a similar modulus of elasticity to the host bone ideal for implant placement.
In the final process of bone formation and maturation, the osteoblast cell will be entrapped at its new residence in the bone matrix and is renamed an osteocyte. Osteocytes reside in lacunae, indicating that the process of bone maturation has been completed (Fig. 11) . In addition to these experiments, we present a clinical case that further illustrates the above-mentioned benefits relating to the in vivo use of the SBRG.
CASE STUDY
A 32-year-old woman presented with a failing right posterior second molar and missing the first molar tooth. Using standard panoramic and periapical radiographs, assessments were made as to the bone height for placement of the endosseous root-form implants (Fig. 12) . Although not realized at the time of surgery because of the limited diagnostic capacity of the panoramic radiograph, there was an area of poor bone quality between the buccal and lingual cortical plates (Fig. 13) . However, the mesially tilted second molar was extracted, and a press-fit cylinder implant was placed anteriorly without incident.
An osteotomy was prepared to place an implant distal to the second premolar tooth. Using the recommended technique, an implant was delivered to the site. Upon releasing the implant from the carrier, and rotating the implant into the osteotomy site, it abruptly dropped into a large cavity in the mandible. The lack of medullar bone between the cortical plates was not detected with conventional radiographs, yet it was a clinical reality. A periapical radiograph was taken immediately. The radiograph revealed the implant lying horizontally near or on top of the mandibular canal (Fig. 14) . Once located, the task of retrieving the implant proved to be a difficult one. In order to visualize the implant and gain proper access, the first fixture placed distally was removed. Under magnification for better visualization, the implant was "backed out" of the original implant's osteotomy, apical end first.
Immediately after the implant was retrieved, the internal cavity was debrided using hand instruments and round burs with irrigation. A combination of radiopaque (ceramic) bovine OsteoGraf 300 (CeraMed, Denver, Colo) and OsteoGen (a radiolucent synthetic, bioactive, resorbable graft) was delivered to the site and expressed through a wide syringe. The grafting composite was condensed thoroughly into the molar site of the large cavity (Fig. 15 ). The first implant was then placed back into the original osteotomy. The tissues were approximated, and primary closure was achieved. Another implant was placed mesial to the second premolar without incident. The grafted site was allowed to heal for 4 months before re-entry. After 4 months, the site was reopened and an osteotomy was prepared into the newly grafted bone. The bone was found to be dense and well compacted. A wider (4.7 mm wide) screw-type implant was then placed into the grafted site (Fig. 16) . A core sample of the bone was taken for histologic examination, including a scanning electron micrograph analysis of the graft composite. The wide implant was allowed to integrate for 4 months prior to loading. All of the implants were then uncovered, and the restorative phase was completed. After 40 months in function, the SBRG radiolucent graft material had a radiopaque denser appearance with well-organized bone formation, and it exhibited no crestal bone loss (Fig. 17) . The molar area exhibited a similar appearance. Figures 18A  and B shows backscattered electron imaging of the human biopsy consisting of SBRG and dense bovine particulates. The SBRG was manufactured at approximately 100°C, and the deorganified bovine particulate materials were sintered at about 1150°C. Only the SBRG is associated with wellorganized bone formation. The remaining crystals are surrounded by well-organized new bone formation concurrent with crystal resorption in such areas (Fig. 18A ). The bovine particulate shows only fibrous tissue encapsulation. In Figure 18B , the specimen consists mostly of bovine particulate encased in fibrous tissue with no visible bone formation. Such material is radiopaque from the day of placement. 
DISCUSSION
The histologic observation from this and other studies relevant to human physiology is that, on the average, connective tissue may migrate on a titanium surface without SBRG as much as 0.5 mm a day, whereas bone may take 3 months to accomplish such a journey, especially, if the surface is smooth. On a roughened titanium implant interface, cells will take longer to migrate because of the "hurdling effect," although adhesion ability to a roughened surface is advantageous for implant stability. This study has demonstrated that the use of the synthetic bioactive, osteoconductive SBRG was able to bridge bone across 8 mm into implant channels against commercially pure titanium in a symmetric fashion without any connective tissue as long as the site was overfilled and well-compacted.
The presence of the low-temperature crystalline material, acting as an intermediate bone-filling substitute next to the titanium implant interface, was associated with a large increase of bone ingrowth. By contrast, unfilled titanium channels have an identical titanium interface filled with connective tissue. At both time intervals, the material showed signs of progressive dissolution and replacement by bone. The remaining SBRG material was firmly incorporated into new bone without any intervening spaces and did not act as a weak point to provide fracture initiation because of a similar elastic modulus as the host bone. SBRG clearly has a bioactive chemotactic response that promotes bone ingrowth into defects through bone attachment and conduction from particle to particle. It is observed by this and other studies that the chemical potentiality may act as a deterrent or minimize connective tissue migration into implant channels. 48 This is in significant contrast to other dense materials (i.e. ceramic HA, glass, plastics, and bovine).
CONCLUSION
Part 1 of this 2-part series presented animal studies that were conducted to evaluate the osteoconductive potentiality of the SBRG, which is a nonceramic particulate of lowtemperature HA material. This study, including a clinical case, evaluated bone-bridging of the SBRG in various restorations. Resorption-rate capacity and cell response were also evaluated, with an assessment of the chemical characterization of the material. Results of the animal studies were compared with human histologic biopsies of the commercial product for bone quality, density, and bone ingrowth into defect sites, especially next to titanium implants and its relationship to the host response. It was concluded that SBRG is ideal for implant placement, providing implant support and bone densification. Additionally, a composite graft mixture consisting of SBRG and mostly dense bovine-derived ceramic HA was compared under electron microscopy. The SBRG material has shown concurrent resorption, excellent bone regeneration, and densification about such crystal clusters without any compromise or adverse effect to implant interface or osseous environment. However, the dense bovine ceramic material (usually sintered above 1150°C) demonstrated fibrous tissue encapsulation about such dense particulates without any evidence of resorption or pitting of the particulate interface. Part 2 will demonstrate clinical applications of the bioactive resorbable material for purposes of implant placement and prosthetic reconstruction.
